Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.
Publication/Presentation Date
11-1-2017
Abstract
Advances in allogeneic hematopoietic cell transplantation for sickle cell disease have improved outcomes, but there is limited analysis of healthcare utilization in this setting. We hypothesized that, compared to late transplantation, early transplantation (at age <10 >years) improves outcomes
Volume
102
Issue
11
First Page
1823
Last Page
1832
ISSN
1592-8721
Published In/Presented At
Arnold, S. D., Brazauskas, R., He, N., Li, Y., Aplenc, R., Jin, Z., Hall, M., Atsuta, Y., Dalal, J., Hahn, T., Khera, N., Bonfim, C., Majhail, N. S., Diaz, M. A., Freytes, C. O., Wood, W. A., Savani, B. N., Kamble, R. T., Parsons, S., Ahmed, I., … Satwani, P. (2017). Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. Haematologica, 102(11), 1823–1832. https://doi.org/10.3324/haematol.2017.169581
Disciplines
Medicine and Health Sciences
PubMedID
28818869
Department(s)
Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute
Document Type
Article